Ingen Technologies owns the patents and trademarks for Oxyview and OxyAlert, and there are no other products that compete or simulate either of these two products within the medical industry, according to the company. The company stated that Oxyview is the world's first in-line oxygen flow meter.Its the new generation of pneumatic safety devices needed in the growing oxygen therapy market.

Patients using portable oxygen concentrators, home oxygen concentrators, liquid oxygen and oxygen gas can use Oxyview® and OxyAlert® to improve their oxygen delivery.

Oxyview® is reusable, requires no batteries, works all the time in any position with all liquid or gas O2 systems, and easily installs anywhere below the cannula nearest the patient where oxygen flow matters the most. Oxygen suppliers, respiratory equipment manufacturers, medical supply stores and patients will appreciate that Oxyview® prevents many unnecessary service calls.

Scott Sand, CEO, said, "The international and domestic market for Oxyview now exceeds $380 million and growing. Our marketing and distribution programs are conservatively aimed at capturing between 1 percent and 2 percent of this market during 2009."